Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-23-000132
Filing Date
2023-02-14
Accepted
2023-02-14 15:51:04
Documents
41
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q restez20221231_10q.htm   iXBRL 10-Q 404035
2 EXHIBIT 31.1 ex_473325.htm EX-31.1 10297
3 EXHIBIT 31.2 ex_473326.htm EX-31.2 10301
4 EXHIBIT 32.1 ex_473327.htm EX-32.1 5245
5 EXHIBIT 32.2 ex_473328.htm EX-32.2 5323
  Complete submission text file 0001185185-23-000132.txt   1773767

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rest-20221231.xsd EX-101.SCH 20668
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rest-20221231_cal.xml EX-101.CAL 15196
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rest-20221231_def.xml EX-101.DEF 75321
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rest-20221231_lab.xml EX-101.LAB 161916
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rest-20221231_pre.xml EX-101.PRE 82013
35 EXTRACTED XBRL INSTANCE DOCUMENT restez20221231_10q_htm.xml XML 98743
Mailing Address 263 EAST 8680 SOUTH SANDY UT 84070
Business Address 263 EAST 8680 SOUTH SANDY UT 84070 888-202-9256
REST EZ Inc. (Filer) CIK: 0001733861 (see all company filings)

EIN.: 824268982 | State of Incorp.: WY | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-56447 | Film No.: 23628245
SIC: 2834 Pharmaceutical Preparations